Mycobacteria-Tbc II  by unknown
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nation of various virulence factors, including their multiple antibi- 
otic resistance, we established pathotypes of isolated bacteria. 
Results: 962 strains, isolated from different clinical material, 
including Staphylocorrus I1 2, Sfrrptoroccus 78, Escherichia coli 230, 
Kk’bsielln 125, Eirterobarter 153, Sa~monella typhimurium 158, 
Pseudomonas 42, and other enterobacteria (Serratia, Moqanella, 
Prutcus) 62, were explored. The adhesive activity was expressed in 
3347.6% of investigated bacteria, and the persistence properties 
(antilysozyme activity) in 39.2-71.8%, and the toxicity (enterotox- 
ins, heniolysins) in 20.3-33.4% of strains of different genera. 
12.3-25.2% of investigated bacteria produced alpha-hemolysins, 
5.1-17.3%1 of investigated bacteria produced thiol-activated 
heniolysins. Pathotypes 2r, 5r, Ss, hr and 6s were predominant among 
observed pathotypes. Dominant pathotypes of bacteria do not 
depend on the systematic position of bacteria. 
Conclusions: The determination of pathotypes of the etiologic 
agents of nosocornial infections promotes the analysis of how these 
infections sprrad. 
5’ACGTATCTGG3’. Amplification of 101) ug of DNA was 
performed in a 100-pL reaction mixture containing 2.5 niM MgCl?, 
200 pM (each) dNTPs, 5U of Taq polymerase and 100 pM of each 
primer. The temperature cycles were raniped as follows: 1 cycle of 
10 at 9 8 T ,  45 cycles of 1 at 94”C, 1’ at 04°C. 2’ at 7 2 T ,  arid a final 
extension step of 10’ at 72OC. Amplified products werc analyzed by 
electrophoresis in agarose gels and visualized by ethidium bromide 
staining. The sizes of the DNA bands were estimated by >tatistical 
analysis calculated with Statview 512+ and the bands were treated 
by using the MA/MAC Fingerprinting program. 
Results: The best results were obtained with R4, AP3 and 
ERIC2 primers. The: band patterns were easily interpretable, the 
fragments were well defined and the nuniber of thcni was up to 34. 
Different profiles were obtained when different species were 
analyzed. The initial denaturation cycle of 10’ at 98°C was extremely 
important to obtain good results. 
Conclusions: O u r  experiments showed that to detrrmine clone 
relatedness, results obtained with two different scyuenccs are needed. 
A factor that strongly affects the standardizkxi of the technique is 
DNA quality. 
1 P432] Is molecular epidemiology of multiresistant 
Enferobacfer cloacae useful for determining a 
nosocomial outbreak? 
Mycobacteria-Tbc I I  
€? Honderlick. F. Saheb, €? Cahen. Microbiologic, Hopital Forh, 
Suresiies, France 
Frequent selection of mutant? resistant to extended- and broad-spec- 
trum cephalosporins in Enterobacter cloacae (Eco) is observed in hospi- 
tals. Eco contributes to a n  increase In the number of cases of 
infections in units in which these antibiotic? are used for curative 
purposes. We noticed an unusual number of isolates of Eco secreting 
a high level ofcephalosporinase, and the question arose whether these 
Eco strains had a common source. We retrospectively studied all 
strains of Eco isolated in our hospital from January to November 
1997. We collected 42 strains of multiresistant Eco from infected or 
colonized patients (Pts), in 1 1  wards of the hospital. Using PFGE 
(pulsed-field gel electrophoresis) with Spel restriction analysis, we 
obtained 27 pulsotypes. We identified a prevalent clone (1 1 patients) 
dispatched in eight wards. We also proved cross-contamination from 
patient to patient, limited only to a few patients in some wards. 
This study confirms the discriminatory power of PFGE and allows 
us to show that an endemic cloning of Eco has taken place during 
the last year in our hospital. Even if there is no real outbreak, the 
reinforcement of basic hygienic measures seems very important to 
suppress the sudden increase in the prevalence of multiresistant Eco. 
/p433] Comparison of different primers to identify 
clinical isolates of Candida spp. by PCR 
M.J. Canduela, L. Gallego, E Lopez-Otsoa, I. Pujana, R. Cisterna. 
Depnrririenr of MirrohioLi,qy, Medicine Faculty, Basque Country 
Lhiiwsity, Spain 
Objectives: Comparison of different PCR primers to decide the 
most suitable for rapid and specific identification of clinical isolates 
of Cnrrdida spp. 
Methods: A total of 176 isolates of Candida spp. obtained 
from different hospitals of Spain were analyzed by RAPD and 
ERIC-PCR. Chroniotomal DNA was isolated by using lytic solu- 
tion containing lyticase, proteinase k and Rnase enzymes. DNA was 
subjected to amplification using the following primers: AP3 
5TCACGAATA3, K4 STGGTCGCGGC.?’, ERIC2 SAAGTAA- 
GTGACTGGGGTGAGCC3’, ERIC1 5‘ATGTAAGCT- 
CTGGGGATTCAC3’, AP2 5‘TCATGATGCA3’, No. 1 
I P434 1 A Mycobacferiurn tuberculosis-specific RDI 
region gene encodes for a seroreactive antigen 
S. Ahmad’, H.A. Amoudy, J.E.R. ThoIe’, D.U. Young, A S .  
Mustafii’ . ‘Department ~fMirro6iok~yy, Faculty (dMcd i r im ,  Kuiuaif 
chicversity, Kuwait; ‘Imperial Co l l ep  Srhool cffMcdirirrc, ~ . w ~ J v ,  CiK; 
.’CIID, TNO Precverition arid Health, Lr iden ,  The Ntvkerlawds 
Tuberculosis (TB), a ‘Global Emergency’, is cauwd by organisins 
belonging to the Myrobacferiurn tuberrulosis complex. Attenuated UCG 
strains of M. bouis have been used as live vaccines against TB with 
limited succesb. New T B  vaccines affording higher protection and 
rapid and sensitive immunodugnostic tools that distinguish TLI from 
other niycobacterial infections are urgently needed. A distinct 
genomic DNA region designated RD I which is present in all v i r w  
lent strains of M. bovrs and M .  tuberrulosis is deleted in BCG strains. 
The RD I region contains 14 open reading frames (OKFs) that cm 
potentially encode 14 M .  tuberrulosis-specific polypeptides. We have 
amplified 6 of these OKFs from the genoniic DNA of i2.I. tubcrcrdo- 
sis by polymerase chain reaction. After confirming the identity of 
each of the amplified ORF by DNA sequencing, 4 of thew OKFs 
were subcloned in pGEX-4T vectors for expression as fusion proteins 
with glutathione-S-transferase (GST). I n  SDS-PAGE gels the 
expressed proteinc appeared as major cellular proteins a t  positions 
expected from their molecular mass and reacted with anti-GST anti- 
bodies. When combined human sera from 11 TB patients were used 
as the source of antibodies, only GST-ORF-14 fusion protein exhib- 
ited reactivity. The protein corresponding to OKF-14 was then puri- 
fied and isolated free of its fusion partner (GST). In Western 
inimunoblors, the OKF-14 protein reacted with antibodies in 31 out 
of 57 (46%) human sera from TB patients while no reactivity was 
seen with 11 sera from M .  bovis BCG-vaccinated healthy subjects. 
Furthermore, sera from 9 out of 15 (60%) long-term contacts of TB 
patients also exhibited antibodies to ORF-14 protein. These results 
suggest the potential utility of ORF-14 protein in the serodiagnosis 
of individuals infected with iZ.1. trtberdosis. 
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lp435) The detection of viable organisms using the 
amplified Mycobacterium tuberculosis Direct 
(AMTD) Test in a patient undergoing treatment 
for MDR tuberculosis (TB) 
M.V. Chadwick, A.M. Middleton, H. Gaya. Microbiology 
Department, Royal Bronipton Hospital, London, UK 
Objectives: To use the AMTD assay (CenProbe) to detect the 
viability of organisms during the treatment of multidrug-resistant 
tuberculosis. 
History: A-67-year old man was referred to this hospital with 
MDRTB. The main was resistant to isoniazid, rifampicin, rifabutin 
and clarithromycin. Treatment was complicated by poor attendance 
and drug-induced hepatitis. Despite institution of directly observed 
therapy (DOT) his disease progressed to involve the left lower lobe 
and the right upper lobe. After 2 months of a five-drug regimen his 
sputum remained smear positive and he underwent a left upper 
lobectomy. His chemotherapy continued. Two weeks after surgery 
the sputum samples were still smear positive. There was an urgent 
clinical need to know if the organisms were viable. 
Results: The AMTD test was carried out. This was positive and 
MDR M. tuberrulosis (Mtb) subsequently cultured. Weekly RNA 
(AMTD) tests were performed to monitor the viability ofthe organ- 
isms. The ligase chain reaction (LCR) (Abbott Laboratories) was used 
concurrently to detect all Mtb, viable and non-viable. 11 samples 
were tested over 5 months. The first 3 only were AMTD positive 
and 2 culture positive. All 11 were smear and LCR positive. 
Conclusions: In this one patient we were able to demonstrate the 
possibility and advantages of nionitoring treatment success in 
MDRTB using the AMTD test; this is not possible with DNA tech- 
niques. 
lp4361 Performance of mycobacterial culture 
confirmation assays on the BDProbeTec ET 
System 
J. Price, S. Bustos, G. Durmowicz, K. Kelly, 0. Llorin, K. Yanson, 
Q. You. Becton Dirkinson Microbioloxy Systems, Sparks, MD, U S A  
Objectives: To evaluate performance of culture confirmation assays 
for the detection of Mycobacterium tuberculosis (M.tb), Mycobarrerium 
avium complex (MAC), and Mycobacterium kansasii (M.kansasii] on the 
BDProbeTec ET system. 
Methods: The BDProbeTec ET systent utilizes strand displace- 
ment amplification (SDA) together with homogeneous detection to 
simultaneously amplify and detect target DNA and an internal 
control sequence. Performance of the BDProbeTec ET culture 
confirmation assays was evaluated for sensitivity, specificity and 
culture media compatibility. Sensitivity was tested by spiking 
BACTEC 12B and MGIT 960 media with strains of M.tb, M. bovis, 
M .  avium, M.  intracellulnrae and M. kansasii. All BACTEC 12B 
cultures were processed and assayed after reaching growth indices 
(Gl) of 4547.  All MGIT 960 cultures were evaluated after achiev- 
ing instrument positivity Specificity was evaluated by spiking each of 
the assays with other mycobacteria and non-mycobacteria isolates at 
10' genome equivalents per mL. To determine media compatibility, 
liquid (BACTEC 128 and 13A, MGIT and MGIT 960, Myco/F- 
Sputa, Myco/F Lytic, and SEPTI-CHEK AFB) and solid 
(Lowenstein-Jensen, selective 7H11 and Ogawa) media were spiked 
at greater than predicted carryover levels in the presence of specific 
target. 
Results: All BACTEC 12B and MGIT 960 cultures evaluated 
(totaI=22) were detected. No cross-reactivity to clinically relevant 
mycobacteria or non-mycobacteria species tested was observed. All 
three assays demonstrated compatibility with liquid and solid media 
tested. Time to results was less than 4 h. 
Conclusions: A sensitive, specific and versatile system that detects 
M.tb, MAC or M .  kansasii from a single culture aliquot has been 
developed on the BDProbeTec ET system. 
v1 Detection of genetic diversity of Turkish 
Mycobacterium tuberculosis isolates using a 
PCR-based typing technique 
R. Durmaz', S. Gunal', B. Durmaz', M. Koroglu', F. Gumuslu' 
'Department of Clinical Micro6iologx Faculty cf Medicine, Inonu 
Utrivusity, Malatya, 'Tn berculosis Rderence and Researrk Laboratory, 
Refik Saydam Hyqiene Center, Ankara, Turkey 
Objectives: To determine the genetic diversity of the Turkish M. 
tuberculosis isolates using a PCR-based typing method and the 
discriminatory power of this technique. 
Methods: A PCR-based typing method that allowed amplifica- 
tion of DNA Gagnients in the insertion sequence IS6110 on the M. 
tuberculosis genome was performed on 181 M .  tuberculosis strains 
recovered from nine different cities. Moreover, 13 strains isolated 
from sputum samples obtained from the members of four different 
families and 15 isolates from epidemiologically unrelated patients 
were analyzed. 
Results: Fifty different genetic patterns with various numbers of 
bands ranging between 1 and 7 were observed among the 181 
Turkish isolates. The vast majority (84%) of the strains yielded less 
than 4 bands. Two genetic profiles either with a 310-bp or a 550-bp 
band were predominant and they were found among the isolates from 
eight cities. Except for two strains, the other epidemiologically unre- 
lated strains yielded unique genetic profiles. On the other hand, simi- 
lar genetic profiles were observed among the strains isolated from the 
same family members. 
Conclusions: According to our results; the resolution power of 
this method is satisfactory for the distinction of epidemiologically 
related and unrelated strains, and the genetic diversity of Turkish 
isolates seems to be lower than those of inany other countries. 
(p4381 Reliability and sensitivity of allele-specific 
amplification of the oxyR and pncA genes for 
rapid discrimination of Mycobacterium 
tuberculosis and Mycobacteriium bovis 
Wei-Juin Su, Reury-Perng. Division of Pulmonary Immunology and 
Inkctious Diseases, Chest Department, Eterans General Hospital, Taipei; 
National Yang-Minx University School cf Medicine, Taipei, Taiwan 
Objectives: To investigate the sensitivity and reliability of distin- 
guishing M.  boois and M. h i s  BCG from other M .  tuberculosis 
complex strains by allele-specific PCR of the oxyR and pnvl  genes. 
Methods: We evaluated the reliability and sensitivity of oxyR and 
pncA allele-specific PCR for differentiating M .  bovis and M .  bovis 
BCG from M .  tuberculosis and non-tuberculous mycobacteria 
(NTM) . 
Results: The results show that both oxyR and pncA allele-specific 
PCR can accurately differentiate M .  bovis and M.  bovis BCG from 
M .  tuberculosis and non-tuberculous mycobacteria (NTM). The 
detection limit of these two assay systems is 50 pg of mycobacterial 
DNA or lo3 cells for the oxyR method, and 500 pg of niycobacter- 
ial DNA or lo' cells for the pncA method. However, a false-positive 
result could be a problem in the oxyR method when large quantities 
(1 0 ng) of DNA template were tested. 
A b s t r a c t s  2 0 1  
Conclusions: It is concluded that these methods are fast and 
sensitive, but false-positive results have a considerable impact on the 
reliability of oxyR allele-specific PCR. We emphasize that care must 
be taken in the clinical application of allele-specific PCR based on 
this target. 
(p4391 lsoniazid action on M. tubercufosis growth 
activity is associated with calprotectin 
concentration 
0. Zalutskaya, I). I'echkovaky. Insritirte of Purrlnrorrolu'qy G Phthisioloyy, 
Mirisk, Belarus 
In a previous study we have shown significant increases in plasma 
calprotectin (0) (MRPWMRP14 protein complex) levels in 
patients with acute pulmonary TB (Pechkovsky D, et al. Tubercle 
Lung Dis 1996; 77(mppl 2): 106), and stimulation of CP effect on 
Mycobatferiir~n rnbercu/osis (MBT) growth in vitro (Zalutskaya 0. 
Quiinioterapia 1997; lO(supp1 2): 67). It was therefore of consider- 
able interest to document the in vitro direct effect of different CP 
concentrationc on isoiiiazid-sensitive MBT strain growth in the pres- 
ence of isoniazid (INH) in liquid nutrient medium. For this aim, we 
uted a colorimetric microassay based on the ability of metabolically 
active cells to reduce diiiiethyltliiazoldiphenyltetrazolium bromide 
(MTT) to formazan. A significant increase of 0.5 mg/mL was found 
with an INH inhibition effect on  MBT growth in the presence of 
10 and 25 nig/mL Cl? While increasing CP concentration dimin- 
ished this effect, so the curve of MBT growth dynamics in the pres- 
ence of INH and 50 ing/mL CP was of the same type as in the 
control (INH alone). It is known that INH denionstrates a bacteri- 
cidal effect on actively growing MBT cultures, so growth stimulation 
by CP in low concentrations potentiates INH action. Thus, INH 
inhibits and CP stimulates MBT growth, and the final result of the 
mutual action CP and INH on MBT growth activity depends on the 
CP and INH proportions in the medium. It can be speculated that 
in vivo during acute tuberculosis treatment with INH, an enhanced 
plasma level of CI' induces direct (stimulation) and indirect (poten- 
tiation of 1NH action) effectc on mycobacterial growth. The prob- 
lem of mutual action of antituberculous drugs and host-derived 
cytokinec on MBT growth has to be studied comprehensively 
IP440] M. tuberculosis drug resistance monitoring in 
Minsk Central TB Hospital (Belarus) 
0. Zalutskaya, L. Surkova, E. Nikolmko, 11. Pechkovsky. Irrstitrrte of 
Pirlmorrohyy G I'ht/ri~io/qp, Minsk, Belaws 
Our study of antituberculous drug susceptibility was performed using 
1490 MBT clinical isolates for 3 years (1992, 1996 and 1997). 
Primary MBT drug resistance rates were observed to be 28.4%, 
36.2'%, and 36.296, and the acquired drug resistance rates were 54.2'%, 
77.2% and 782%) respectively. Changes were observed in the struc- 
ture of drug resistance since 1992. Among primary resistant strains, 
resistance to one antituberculous drug was found in 41.7%, to two 
drugs in 41.6'%, and to three and more drugs in 16.7% in 1992; to 
one drug in 22.396, to two drugs in 18.8% and to three or more drugs 
in 58.8% in 1996; and to one drug in 32.2'%), to two drugs in 23.1% 
and to three or more drugs in 44.6% in 1997. Similarly, among 
acquircd resistance strains the resistance rate to one antituberculous 
drug was found in 37.5'36, to two drugs in 31.3% and to three or more 
drug  in 31.2% in 1992; to one drug in 6.7%, to two drugs in 17.8% 
and to three or more drugs in 75.7% in 1996; and to one drug in 
6.9'%1, to two drugs in 12.6% and to three or more drugs in 80.4% in 
1997. Resistance was found to SM in 82.7% among resistant strains 
isolated from untreated patients and in 86.4% among resistant strains 
isolated from treated patients, to INH in 60.3'%1 and in  X4.5%1, to RIF 
in 48.8% and in 75.4'%1, to KM in 27.3% and in 35.7'%, to ETA in 
9.0'% and in 30.6%, to EMU in 4.9% and in 11.7% respectivcly in 
1997. We would like to emphasize that most resistant MBT strains 
in our region are resistant to first-line antituberculous drugs, The 
high rate and increase in acquired drug resistance, as wcll as the 
increase in MDR-TB, shows a low efficiency of T B  patient treat- 
ment. Thus, iiionitoring of MBT primary and cicquired resittancc is 
necessary for the indirect control of the efficiency of the national 
tuberculosis program. 
Rapid molecular methods for the detection of 
isoniazid resistance of Mycobacterium 
tuberculosis clinical isolates in Greece 
G. Vrioni',', E. Marinis', P. Matsiota-Bernard'. 'Norronal RCfercrire 
Ccriter Jbr   myt to bar re ria, Athens, Greetre; 'L.a/iovatoirre dc i2ilicrt~bio/qyie, 
Hopifal Raynioiid Poicare, Paris, France 
Objectives: Our main objectives were to determine whether mole- 
cular methods can be used for routine diagnosis of isoniazid (INH) 
resistancc in Myroobacterirrm 1rr6~rcuiosis isolates, as well a \  whether the 
molecular events occurring in INH resistance in Greece are different 
froin those occurring in the other Western countries. 
Methods: We studied 44 INH-resistaiit M. tirbr~rrirlosis clinical 
strains from Greece isolated over a 2-year period. The detection of 
INH resistance was performed by two niolecular methods. PCR- 
single-stranded confoi-niation polyniorphism (SSCP) analysis was 
used for k a G ,  iuhA and ahpC gene deviations, and I'CK-restriction 
fragment length polymorphism (KFLP) analysis for the detection of 
the kaiG locus polymorphism. 
Results and conclusions: We found that I'CII-SSCP analysis 
had a specificity of 100% and a sensitivity that varied from 7% to 45%. 
With PCR-RFLP, the mutation a t  serine 31.5-threonine in the knrG 
gene can be detected with excellent specificity and good sensitivity. 
Molecular detection of resistance can be accomplished accurately by 
PCR-SSCP analysis, as well as by PCK-KFLP, but they cannot 
replace traditional methods. Finally, the molecular events detected in 
the Greek INH-resistant isolates do not differ from those described 
in other Western countries. 
Comparison of molecular techniques for the 
typing of Mycobacterium tuberculosis 
G. Vrioni'.', E. Marinis', l? Matsiota-Bernard'. 'Nariorinl RCfircncc~ 
CctiferJbr .VJyro6acterin, Athens, Grrecc; 'Luboratoirc de Microhiuilyi~~, 
Hopiral Rapnorid Poirare, Paris, France 
Objectives: The identification of the source of infection with 
Mpbac ter i r rv~  tnberrnlosis is important for limiting the dissemination 
of tuberculosis. 
Methods: In this study we compared restriction fragment length 
polymorphism (RFLP) analysis using the insertion element IS61 10 
and randonily amplified polymorphic IINA (RAPD) aiialysis using 
three or one arbitrarily chosen primers for the typing of M.  tirbcrcir.. 
loris icolates. The isolates included in the comparative study were 
related or unrelated and were of the wild type or retistant to ison- 
azid and/or rifatnpin. 
Results and conclusions: We found that the three molecular 
typing methods gave very satisfactory results and can be used for the 
epidemiology of tuberculosis. The RAPD analysis, howcver, seems 
to be easier to perform than the KFLP analysis, even when J non- 
radioactive probe is used 
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lp4431 Use of antibody immune adsorption and 
competence for optimizing tuberculosis 
diagnosis in ELISA 
0. Kalechits, A. Lysenko, L. Surkova, V. Borshchevsky, T. Ageeva. 
Institute oj Pulntonology and Phthisiology, Minsk, Belarus 
Objectives: ELISA sensitivity to antibodies in tuberculosis varies 
widely Some possibilities of increasing ELISA diagnosis sensitivity by 
optimizing the technique of revealing the antibodies, as well as of 
detecting antigens of Mycobacterium tuberculosis circulating in blood, 
both independently and in immune complexes, were studied. 
Methods: The immune dominant antigens of the cellular walls of 
Mycobacterium tuberculosis H ~ ~ R v ,  variants of immune adsorption of 
the antibodies and antigens present in the studied samples were used 
for ELISA. 62 samples of blood serum from patients with tuberculo- 
sis of the lung, 30 from persons with non-tuberculous diseases of the 
lung, and 20 samples of blood serum from clinically healthy donors, 
were studied. 
Results: I t  has been determined that the sensitivity can be 
increased from 32.5% to 57.5%, and the specificity from 36.7% to 
93.3%, by registering the studied blood serum activity changes after 
introduction of specific antigens. An additional study of the serum 
samples by the method of the bovine antibodies to the M .  tuberculo- 
sis antigen complex allowed an increase in sensitivity up to 67.5% 
the positive results being obtained only in determining the free anti- 
gens or the bound ones in 7.5% of samples. 
Conclusions: The expediency of correcting the traditional 
approaches to serologic diagnosis of tuberculosis is shown. A test 
system allowing the determination of the mycobacterium antigens in 
biological fluids in addition to antibodies has been developed. 
m1 Microbiological properties of different drug 
sensitivity Mycobacterium tuberculosis 
isolates from patients with acute pulmonary 
tuberculosis 
H. Hurevich, 0. Zalutskaya, S. Oknlovskaya, E. Nikolenko. 
Institiire ofP&onofogy G Phhtlziriolog~ Minsk, Beiams 
The aim of this study was the evaluation of the microbiological prop- 
erties of Mycobacteriirm tuberculosis (MBT) strains (drug sensitivity, 
virulence, number and time of appearance ofvisible colonies on solid 
medium) isolated from 160 patients with acute pulmonary TB before 
treatment. The preparation of sputum specimens was performed 
using conventional methods. Samples were inoculated onto slants of 
egg-based solid medium and incubated at 3 7 T  for up to 2.5 months. 
The visual evaluation of number and time of appearance of visible 
colonies was performed weekly Susceptibility testing was performed 
by the conventional method on Lowenstein-Jensen medium. 
Virulence of 50 MBT isolates was determined by infection of guinea 
pigs via subcutaneous injection of 0.05 mg of MBT bacteria. The 
virulence index was calculated as described by Mitchison. All evalu- 
ated isolates were divided into three groups according to drug sensi- 
tivity (group 1, drug sensitive; group 2, resistant to 1 drug; group 3, 
resistant to 2 or more drugs). The number and time of appearance of 
MBT visible colonies on solid medium and virulence of MBT 
isolates were compared in three groups. A significant increase in mean 
time of visible MBT colony appearance was observed in group 3 as 
compared with groups 1 and 2, and a significant increase in the 
number of visible colonies was observed in group 3 in comparison 
with groups 1 and 2. A significant difference in average values ofviru- 
lence indexes between drug-sensitive and drug-resistant MBT strains 
was also observed. Thus, we observed differences in the microbio- 
logical properties of MBT strains with different drug sensitivities. 
[m] Indirect ELSA and monospecific polyclonal 
antisera for quick differentiation of 
mycobacteria in diagnostic inoculations 
L. Surkova, A. Lysenko, 0. Kalechits, V. Borshchevsky. Institute of 
Pulmonology and Phthisiolofy, Minsk, Belarus 
Objectives: To investigate the possibilities for identifying mycobac- 
teria in inoculation using ELISA. 
Methods: Exposure of ovine and rabbit antisera to ultrasound 
disintegrates the bacterial mass of M. tuberculosis H&v, M.  bovis 
Vallee and the mixture of M .  kansacii D4/74 and M.  scrojulaceum 526. 
M .  terrae 5922, M.fortuitum 342 and M .  avium 1603 were used in the 
study. The group of specific antisera to the complex of M.  tubercirlo- 
sis-M. bovis, and to the atypical mycobacteria antigens as well as the 
monospecific ones to M .  tuberculosis and to M.  bovis, were prepared 
by cross-immune absorption. For the test, 1-2 colonies were taken 
off the solid culture medium surface, suspended in the carbonate- 
bicarbonate buffer, and heated in the boiling water bath for 2C-30 
min. The heated suspension was placed into the immunologic panel 
cavities and then ELISA was conducted in accordance with the 
generally adopted technique using the prepared antisera. 46 cultures 
isolated from humans and 10 cultures of atypical mycobacteria 
isolated from cattle, which were previously identified by the gener- 
ally adopted tests, were studied. Six mycobacteria standard strains 
served as a control. 
Results: 41 cultures of 46 isolated from humans were attributed 
to M .  tuberculosis-M, bovis. Four were attributed to atypical mycobac- 
teria, corresponding to the results of the generally adopted tests. One  
culture of M.  tuberculosis gave an indefinite result. The 10 cultures 
isolated from animals were identified as atypical mycobacteria. While 
differentiating cultures inside the complex M. tuberculosis-M. bovis, 
the standard cultures were identified correctly. 39 of 41 diagnostic 
cultures were defined as M .  tuberculosis. Two cultures gave an indefi- 
nite result. 
Conclusions: Use of the developed test system allows differenti- 
ation of mycobacteria within 1 day with an accuracy of 95-98%. 
/p4461 The Griss method in early detection of 
sensitivity of M. tuberculosis 
V Golyshevskaya, S. Safonova, V. Puzanov. Central TB Research 
Institute ofthe Russian Academy $Medical Sciences, Moscow, Russia 
Objectives: To improve the routine microbiological method of 
absolute concentrations for rapid drug susceptibility testing of M.  
tuberculosis. 
Methods: For early detection of drug resistance we tested the 
nitrate rednctase activity of mycobacterial culture using the Griss 
reagent. Mycobacteria were cultured using solid egg media with 0.1% 
NaNO3. Control isolates were cultured using the BACTEC 460 
system and conventional protocols. 
Results: Comparison of our results with those obtained using the 
BACTEC 460 and routine methods showed a 96% coincidence of 
drug resistance testing results. 
Conclusion: The use of the Griss reagent provides for early 
detection of drug resistance (within 8 - 10 days). 
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Mutations of the rpoB gene in rifampicin- 
resistant isolates of M. tuberculosis from 
Russia 
A. Khonienko’, Yu. Lopukhin’, E. Generosov’, V Govorun’, L. 
Chernousova’, V Golyshevskaya’. ’Central TE Research Iustitutc of 
tlic Rirssian Academy qf Medical S&nces, 
Clrrniical Medicinc, Musro iq Rus.ua 
Objectives: Detection of mutations of the rpoB gene in niultidrug- 
resistant strains of M. rirbercnlosis isolated from patients from Russia. 
Methods: Detection of drug resistance was periornied using the 
absolute concentrations method. Direct sequencing of the PCR- 
amplified fragments of the rpoB gene Wac used to study 52 rifampicin- 
resistant and 48 sensitive clinical isolates. 
Results: 51 (98%) of the 52 rifauipicin-resistatit isolates had resis- 
tance-associated genoinic mutations in the rpoB gene. 24 strains 
(46%) had a mutation at codon 531, 20 strain$ (23%) had a mutation 
at codon 526 and 20 (23%)) had a mutation at codon 516. No muta- 
tions were found in 48 Rrifampicin-sensitive strains. An unusual 
double mutation combining the 516 codon (niethionine) deletion 
and 514 (F-L) tubstitution was observed in a single rifampicin-resis- 
tant strain. 
Conclusions: Direct sequencing of the PCR-amplified fragments 
of the rpoB gene could be a useful tool in detecting rifainpicin resis- 
tance of clinical isolates of M.  tuberculusis. 
Resenrclt Institute o j  Dltysicu- 
/p448/ Use of the MB/BacT in species identification 
J. Beer, A.C. Rodloff, Ilrrivcrsity hi&, Iust. .for Med. Microbiuloxy, 
Leipzi~, Germany 
Objectives: Since susceptibility testing of strains of the Mycobacterium 
t u b ( w h s i s  complex with the MB/Bact is usually completed within 
approximately 8 days, the present study was aimed at achieving the 
appropriate tpecies 01- variant ideutification within the same time 
franic. To serve this purpose, gene probe results were suppleinented 
with niacin and nitratase tests that were adapted to the MB/BacT. 
Methods: Earlier, it has been suggested to expedite niacin and 
nitratase tests by uting fluid culture inocula rather than growth from 
solid media. We uwd 0.5 inL of MB/BacT cultures that displayed 
sufficient growth for fluid susceptibility testing and added this ‘orig- 
inal suspension’ to 0.5 niL medium contaming 0.5% asparagine, incu- 
bated at 36OC, and developed the niacin test the same day the 
susceptibility test was terminated. Likewise, 0.1 niL of the original 
suspension was added to 0.9 mL medium containing 0.1% KNCh, 
incubated at 36”C, and KNO2 production was read when the control 
culture showed detectable growth in the MB/BacT system. Standard 
assay cystems have been used 3s controls. Altogether, 14 strains (10 
M.  tuberculosis, 1 aj i ranuni  variant, 1 M. bovis and 2 BCC) were tested. 
Results: In all cases fluid culture test results were identical to 
results of conventional assay systems starting from culturec on 
Lowenstein-Jeiisen medium. 
Conclusions: With the proposed method it is possible to accel- 
erate test results and make them available at the time when suscepti- 
bility tests are read. 
lp4491 MOTT infections in immunocompetent 
patients 
R. Mazzolla, A.M. Covarino, M. Finamonti, S. Mincigrucci, M 
Buratta, T. Sposini, G. Sbaraglia, F. Bistoni. Exp. M e d .  Eiorhenz. 
S i . ,  Mirrobio/ocqx Pcrugia, Italy 
Objectives: Identification of niycobacteria other than iWyalbar~eriunz 
tnberccdosis (MOTT) in imniunocompetent hosts. 
Methods: From 1 January 1990 to 31 December 1997, 1741 
samples from the Institute of Occupational Medicine and 315 samples 
from the Institute of Pathology were examined for MOTT infvctions. 
All samples were cultured on Lowenstein-Jensen egg medium and in 
Middlebrook broth inediuni (Bactec system 460). Strains were iden- 
tified by standard biochemical tests. 
Results: M O T 7  were isolated in 130 cases including redandant 
samples: 07 (51%) from the urinary tract and 63 (48%1) from the respi- 
ratory tract (sputum, pulmonary biopsy, bronchoalveolar lavage). M. 
gordonae (1 9%) and M. wenopi (14%) were the most frequently isolated 
species. Retrospective analysis revealed that 71 patients had a history 
of clinical syniptonis (chronic pulmonary diseases), 23 had previoiisly 
acquired MOTT diseases, and in 36 pulmonary infections were 
predominant when hospitalized. Infiltrates or other roentgeno- 
graphic indications of disease were observed in 98 (75%) of the 130 
cases. No disease other than M O T T  infection was obterved in 102 
patients (78%). 
Conclusions: Our data indicate that clinical features are nnpor- 
tant factors in the diagnosis of MOTT infection$. Predisposing 
conditions, such as chronic pulmonary disease, are required for thece 
emerging infections. Roentgenographic evidence and repeated isola- 
tion of M O T T  are possible factors for diagnocic of disease. Further 
studies on the significance and outcome of these increaeing infections 
are needed. 
Clinical evaluation of the BDProbeTec ET 
System for the direct detection of 
Mycobacterium tuberculosis complex from 
respiratory specimens 
IS. Bcrgmann, G.L. Woods, University o j  Texar. Dcpt. 4 Pafhohqy, 
Galveston, rx, USA 
Objectives: To evaluate the performance of the BDProbeTec ET 
Sycteni for the direct detection of Mycobacterirrm ruberculosis complex 
(MTUC) from respiratory specimens. 
Methods: From 134 patients, 245 respiratory specimens were 
decontaminated and concentrated, a smear was prepared fix Auramine 
0 staining, culture media were inoculated, and two 500-niL aliquots 
were frozen at -20°C. One aliquot was processed and assayed by the 
BDProbeTec ET System. Results were compared to ciiiear and 
culture. 
Results: O n  initial testing, two specimens could not be inter- 
preted due to failure of the internal control to amplifi, thus produc- 
ing an indeterminate result. Upon repeat testing, one specimen was 
positive; the second produced an indeterminate result and was 
excluded from the analysis. Thirty specimens were culture positive 
for mycobacteria, 11 (eight patients) of which were MTBC. The 
BDProbeTec ET System results were positive for all eight smear- 
potitive specimens that were culture positwe for MTBC, and for two 
of three smear-negative specimens (two patients) that were culture 
positive for MTBC. There was one BDProbeTec ET System-poci- 
tive, culture-negative specimen. The sensitivity and specificity of the 
BDProbeTec ET System were 90.9%) and 99.6% respectively. After 
reviewing patients’ records to resolve discrepancies, these values were 
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unchanged. Average time to the BDProbeTec ET results was 3.5 h 
for 15 specimens. 
Conclusions: Although the number of patients with tuberculo- 
sis in our study is small, these data suggest that the BDProbeTec ET 
System is a sensitive technique for detection of MTBC directly from 
respiratory specimens. Additional studies are ongoing. 
(p451j Detection and identification of mycobacterial 
isolates from human clinical samples 
T.V. Grebennikova, E.A. Nepoklonov, Iuunousky Virology Institute, 
Rt3D Department, Moscow, Russia 
Tuberculosis is a worldwide health problem and may be the most 
common cause of deaths from a single infectious agent. There are 
numerous species of mycobacteria, and the diagnosis of tuberculosis 
is a very important task. The conventional method for detection of 
mycobacteria in clinical saniples is based on the demonstration of the 
acid-fast organisms following cultivation. Polymerase chain reaction 
(PCR) is a simple and rapid test, useful in detecting M .  tuberculosis 
complex. We have developed three specific primer sets for detection 
of DNA from M .  tuberculosis, M .  bovis and other strains of mycobac- 
teria. Here we present the results of differential detection of myco- 
bacteria by ‘nested’ PCK in isolates from human clinical samples. 
DNA samples were taken from 70 cultures, obtained from the 
patients with mycobacterial infection during 1995-97. The samples 
were tested for drug resistance. Presence of mycobacteria in these 
samples was confirmed by cultivation. Sixty-four cultures ofM. tuber- 
culosis, three cultures of M. bouis and three cultures of other strains of 
mycobacteria ( M .  smegmatis and M .  fortuitum) were identified by 
differential PCR diagnosis. The presence of M. smegmatis and M. 
forttritum was confirmed by restriction enzyme analysis. Good core- 
lation was observed between the data obtained with the PCR 
method and the results of cultivation. Thus, PCR proves to be a 
specific, rapid and sensitive test for differential diagnosis of mycobac- 
teria in clinical samples from humans. 
[m Comparison of four different mycobacterial 
antigens in the challenge of tuberculosis 
serodiagnosis 
D. Marchetti, A. Favero, M. Dallera. Bellaria Hospital, Bologna, Italy 
Objectives: To compare four immunoserologic tests in TB patients 
using different mycobacterial antigens. 
Methods: In some TB cases, where it is dificult to achieve niate- 
rial from the foci of infection for microscopy and culture (like extra- 
pulmonary TB or small children), serology can play a useful role. 
Sensitivity and specificity of serologic tests are strictly related to the 
chemical composition and purification of the antigens used. Antigens 
utilized are: A60, a macromolecular antigen derived from tuberculin 
RT 23, lipoarabinomannan (LAM), a lipopolysaccharide antigen, 
Path TB complex, recombinant antigen of 38 kDa from E. coli, and 
Path Myco IgG and IgM, a mixture of recombinant 38-kDa antigen 
and a highly purified antigen extracted from M. tuberculosis. In our 
study we tested 80 subjects, 40 patients with active pulmonary TB, 
20 with extrapulmonary tuberculosis, 10 TB contacts and 10 blood 
donors. 
RESULTS ACTIVE TB EXTRAPUL TB TB CONTACTS BLOOD DONORS 
N-cazes 40 20 10 10 
13% 45 % 20% 20% 
40% 55% 10 % 1 0% 
65% 30% 10 % 1 0% LAM 
PATHTBcomplex 40% 20% 0% 0% 
P A w M v C O g G  85% 85% 20% 10% 
PATH MYCO IgM 55% 45% 20% 20% 
% g 
Conclusions: Path Myco IgG and A60 show the best sensitivity 
both in active and in extrapulmonary TB. LAM and Path TB 
complex seem less sensible The best specificity is detected in Path TB 
complex. The other antigens show false positives in 1G20% of cases. 
1p4531 Genotypic identification of mycobacterial 
species 
I .  Mokrousov’, 0. Narvskaya’, T. Otten’, B. Vishnevsk?. ’Pasteur 
Institute, 21nstituteAP-PCR/hybridization of Phtislopulmonologx St 
Petersbuz, Russia 
Objectives: The interspecific genetic discrimination of some myco- 
bacteria (M.  tuberculosis, M .  africanum, M .  bouis BCG, M .  bovis, M .  
avium, M. intracellulare, M. kansasii and M. fortuitum). 
Methods: PCR-ribotyping (restriction enzyme (RE), analysis of 
amplified 16s-23s ribosomal DNA spacer) and arbitrary PCR 
followed by cross blot hybridization of amplified DNA. 
Results: Intraspecific identity of the rDNA restriction profiles was 
found for the mycobacteria studied, in particular for M. tuberculosis 
complex. Different RE revealed different levels of interspecific diver- 
sity. M .  avium and M. intracellulare differed in 3 of 5 RE. All the species 
(except M. fortuitum) were identical in RSA 1. AP-PCRIhybridiza- 
tion analysis revealed homology for M.  tuberculosis complex strains, 
thus confirming that they belong to the same genetic species. In 
contrast, no or weak residual homology was found between M.  avium 
and M. intracellulare that corresponds to total DNA-DNA reassocia- 
tion data. 
Conclusions: AP-PCR (hybridization variant) may be used for 
revealing the identity of the strains at the genospecies level as a tech- 
nique comparable in reliability to traditional DNA-DNA reassocia- 
tion. In contrast, PCR-ribotyping may be suggested as a rapid 
method for species differentiation and identification of mycobacte- 
ria. 
Directed observed antituberculous 
chemoprophylaxis in intravenous drug 
abusers on a methadone program 
J. Martinez Lacasa, N. Freixas, M. Del Rio, M. Garcia, M. Riera, 
I. Gbmez, J. Julia, J. Garau, Hospital Mutua de Errassa, Internal 
Medicine, Errassa, Spain 
Objective: To evaluate the safety and adherence of directed observed 
antituberculous chemoprophylaxis (DOTCH) in intravenous drug 
users (IVDUs) who are receiving methadone for their addiction 
Methods: We analyzed all patients included in a methadone 
program from January 1997 to October 1998 in our hospital. A PPD 
(rt23) was done followed by a chest X-ray in PPD-positive patients 
(5 mm). In infected patients, prophylaxis with isoniazid (INH) was 
proposed. One group of patients received daily INH (5 mg/kg per 
day) and a second group received INH 2 days weekly (15 mg/kg per 
day). Both groups received a 12-month chemoprophylaxis course 
Results: Sixty-eight patients were studied; 21 of 68 (30.8%) were 
PPD (+). Mean age was 30*8 years; 17 were men and four women. 
In 6 of 21 (28%), an examination of the sputum to rule out tuber- 
culosis was performed because of chest X-ray abnormalities. No case 
of active tuberculosis was detected. In 19 cases prophylaxis was 
proposed. Eight patients had DOTCH with INH once a day and 
seven had INH twice a week. One patient received both rifanipin 
and INH for 4 months because of fibrotic infiltrates in the chest film 
and negative sputum cultures. Three patients discontinued DOTCH 
in the first month. The rest of the patients finished it correctly. We 
have not stopped any prophylaxis due to toxicity but in four patients 
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a transient increase in transaniinases was observed (less than X 3  
baseline value). Mean follow-up of patients from the start of 
DOTCH was 2 7 0 t 3 5  days 
Conclusions: IVDUs on a methadone program are at high risk 
of tuberculosis because of the high incidence of tuberculous 
infection. In this population, to assure good adherence, directed 
observed prophylaxis is needed; probably (study still ongoing), INH 
twice a week is cost-effective. In our present experience, tolerance 
and adherence are quite satisfactory. 
Viral diagnostics 
Laboratory diagnosis of hepatitis B virus (HBV) 
infection: the role of serum HBV-DNA 
assessment. 
M. Saber’, H. Badawey’, M. Onia?, A. Abu-Aitta’, M. El- 
Hamshary ’ . ‘Bioclienristry and ’A4icrobiolqy Deparhncrits, Theodor 
Bilharz Research Institute, Egypt 
Objectives: (1) To assess the role ofHBV-DNA in diagnosis ofHBV 
infection. (2) To study the distribution of different HBV serologic 
profiles among acute and chronic hepatitis B cases. (3)  To evaluate 
the diagnostic efilciency of different assays for serodiagnods of HBV 
infection. 
Methods: Serum samples from 100 HBV cases were studied for 
HBV markers (HBsAg/Ab, HBeAg/Ab, HBctotal/IgM) using 
ELISA, Dot-ELISA and ininiunodiffusion techniques. HBV-DNA 
was studied by the spot hybridization method. 
Results: HBV-DNA was detected in 96.7% of acute and 29.6% 
of chronic cases. HBeAg minus profile represents 41.3% of acute and 
75% of chronic hepatitis B cases. Dot-ELISA showed 100% sensitiv- 
ity and 98.3% specificity as compared with ELISA test. 
Conclusions: Significant correlation was found between HBV 
viremia and HBV-DNA positivity The HBeAg minus mutant of 
HBV characterizes the major infective agent in HBV infection in 
Egypt. Dot-ELSA can substitute for conventtoiial ELISA, especially 
in screening large numbers of samples. 
lp455) Molecular characterization and sequence 
stability of the hepatitis B virus surface gene in 
children treated with interferon 
H.-F. Liu’, E. Sokal’, P. Goubau’. Utzits .f ’Virology a n d  ’Pcdiatrir 
Gastroenterolqqy 6 Hepatology, University Hospital St-Lur, Uirivcrsity of 
Lotciain, Bnrsse~s, Be[qiirm 
Objectives: To investigate the stability of hepatitis B virus (HBV) 
surface (S) gene in 23 children under interferon (IFN) treatment in 
Belgium by comparing the sequence of serial saniples taken before 
and after treatment. We also studied HBV genotypes and serotypes 
in this patient population. 
Methods: A 736-bp fragment spanning the 3-end of pre-S and 
almost the entire S genes of the HBV genome was amplified and 
sequenced. Together with other strains ofdifferent geographic origin, 
phylogenetic analycis was performed using three different methods. 
Results: Twelve of the 23 pediatric patients were found to have 
a response to IFN treatment. Except for 4 patients, no sequence 
change was observed before and after IFN treatment. These DNA 
sequence changes (or mixed nucleotides) did not change the amino 
acid sequences of the HBsAg and the polymerase in 3 patient$. The 
other strain has mixed nucleotides which encode two different amino 
acids. Four different genotypes (A, B, I), E) were f&nd among the 
23 patients. Most of them were types A and D. 
Conclusions: A great genomic sequence stability of the S gene 
was found under IFN treatment. The high diversity of HBV grno- 
types reflects the fact that most children are adopted and  is concor- 
dant with their geographic origin?. The response to IFN treatment 
is not correlated to HUV genotypes. 
Lp4561 IMMULITE Anti-HBc for detection of serum IgM 
M. Ghadessi, J.-D Lei, D. Sustarsic, A.S. El Shanii, Diajriosrir 
Prodircts Corp., Researrh and Develiipntent, Los Any&c, CA, I JSA 
Objectives: IMMULITE Anti-HBc IgM is a n  automated, solid- 
phase, two-step cheniiluminescent enzyme inimunoacsay. The 
purpose of this study was to evaluate the perforinance of the 
lMMULlTE Anti-HBc IgM against another EIA assay. 
Methods: Enclosed within the proprietary IMMULITE Test 
Unit is a polystyrene bead coated with a niurine monoclonal anti- 
body specific for IgM. Patient sample and buffer reagent are simul- 
taneously introduced automatically by the IMMULITE into the test 
unit and incubated for 30 min. After a spin-wash, sample, cxcess 
reagent and wash solution are captured in a coaxial waste chamber. 
An alkaline phophatase-labeled recombinant HBcAg is then added. 
Following another 30 min of incubation and wz\h, enzyme label ic 
measured with a cheniiluminescent substrate, a phosphate ester of 
adniantyl dioxetane. A quantitative result is obtained by coinparing 
the patient result to an internal standard curve calibrated to the PEI. 
A collection of 155 seruni samples was tested by both the 
IMMULITE and Abbott Corzyme-M (rDNA) assays. 
Results: The relative sensitivity and specificity values for the 
IMMULITE assay were 90.3% and 97.6% in comparison to the 
Corzyme-M assay, with 95.5% agreement between the two assays 
Conclusion: The excellent performance characteristics of the 
IMMULITE Anti-HBc IgM assay make it suitable for use in the diag- 
nosis of acute or recent hepatitis B viral infections. 
lp4571 Comparison of IMMULITE 2000 Anti-HBc to 
Abbott 
D. Burns, C. Ccrvantes, R. Gonzalez, M. Ghadessi, S. El Shami. 
Diqrrostir Prodiirts Corporarioii, L i s  Anjeies, CA, LX4  
Objectives: To evaluate the performance characteristics of the 
IMMULITE 2000 Anti-HBc assay (Thgnostic Products Corpor- 
ation, Los Angeles, CA) for detection of total antibodies to hepatitis 
B core antigen (anti-HBc). 
Methods: The performance of IMMULITE 2000 Anti-HBc was 
compared to the Abbott CORZYME assay (Chicago, IL) using the 
Anti-HBc Total Sensitivity Panel (PHG804) and Anti-HBc Total 
Mixed Titer Performance Panel (PHG201) purchased from Boston 
Bioniedica, Inc. (west Bridgewater, MA). 
Results: The Anti-HBc Total Sensitivity Panel (PHG804) and 
Anti-HBc Total Mixed Titer Performance Panel (PHG201) were 
evaluated with the IMMULITE 2000 Anti-HBc and the Abbott 
CORZYME assays. Based on the sensitivity panel, the IMMULITE 
2000 assdy was sensitive to 1.5 Paul Erhlich Institute (PEI) units/mL. 
In comparison, the Abbott assay detected total anti-HUc down to 1 .O 
PEI U/mL. The difference in functional sensitivity was nlininial as 
noted in the comparison between the two assays on thr mixed titer 
perforinance panel. The results from the mixed titer performance 
panel demonstrated that the IMMULITE 2000 .issay correlated well 
with the Abbott CORZYME assay, with 100% agreement. 
